WorldBreaking NewsBreakingLatest News
Chinese Genetic Sequencing Firm Novogene Sues Pentagon Over Military Blacklist
Sentiment: NeutralHigh Priority
What Happened?
Novogene, a Chinese genetic sequencing company, has filed a lawsuit against the U.S. Department of Defense, challenging its inclusion on a military blacklist. The company claims the designation is unlawful and harmful to its business.
Key points
- Novogene filed the lawsuit in a U.S. District Court in Washington.
- The Pentagon designated Novogene as a 'Chinese military company' in June.
- The designation restricts the Pentagon from contracting with Novogene.
- Novogene employs around 180 people in the U.S.
- The company denies any military links and claims the designation has caused significant harm.
- Other companies, including Alibaba and BYD, are also challenging their inclusion on the list.
Key insights
- If Novogene wins, it may lead to a reevaluation of the Pentagon's criteria for military designations.
- The case highlights ongoing tensions between the U.S. and Chinese technology firms.
- A favorable ruling for Novogene could encourage other companies to challenge similar designations.
Why it matters
The outcome of this lawsuit could impact Novogene's business operations and reputation significantly.
Entities
Novogene· CompanyPentagon· OrganizationAlibaba· CompanyBaidu· CompanyBYD· CompanyNIO· CompanyDJI· CompanyWuXi AppTec· CompanyCalifornia· StateOregon· State
Source
Times of India
